[Advances in the management of heart failure]

Luigi Tavazzi1

  • 1Maria Cecilia Hospital, GVM Care & Research, Cotignola (RA).

Giornale Italiano Di Cardiologia (2006)
|January 20, 2021
PubMed

Insights

This review discusses key clinical cardiology aspects of heart failure (HF), including its definition, subtypes, sudden death, genetics, and artificial intelligence applications, offering a practical perspective beyond standard guidelines.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Research

Background:

  • Heart failure (HF) presents a complex syndrome with ambiguous definitions and varied patient responses to treatment.
  • Current guidelines may not fully address all clinically relevant aspects of HF management.
  • Active research areas offer opportunities to refine our understanding and treatment of HF.

Purpose of the Study:

  • To provide a clinical cardiology perspective on current, research-active aspects of heart failure.
  • To discuss key points beyond established guidelines, focusing on practical implications.
  • To highlight emerging trends and challenges in HF research and management.

Main Methods:

  • Literature review and synthesis of current research findings.
  • Clinical interpretation of data related to HF definition, subtypes, and associated conditions.
  • Discussion of emerging technologies and genetic factors in HF.

Main Results:

  • The definition and boundaries of HF remain areas of active investigation.
  • Distinctions between HF with preserved ejection fraction (HFpEF) and HF with reduced ejection fraction (HFrEF) continue to evolve.
  • Research is advancing in areas including sudden death risk, population genetics (polygenic risk scores, OMICs), atrial fibrillation ablation in HF, and the integration of artificial intelligence in HF care.

Conclusions:

  • A nuanced understanding of HF, incorporating evolving definitions and research advancements, is crucial for effective clinical management.
  • Addressing specific challenges like HFpEF, sudden death, and atrial fibrillation requires tailored approaches.
  • The integration of advanced tools like AI and genetic insights holds significant promise for future HF patient care.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
92
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
108
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
248
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
135
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
671
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
124